Home / Weight Management / RETAKLIK 2.0 (RETATRUTIDE + CAGRILINTIDE) 30+5mg
RETAKLIK 2.0 (RETATRUTIDE + CAGRILINTIDE) 30+5mg
RETAKLIK 2.0 is a research compound featuring a combined formulation of retatrutide and cagrilintide, supplied in a 30+5mg quantity.
£202.50Size
Order before 2pm for same-day dispatch
Shipped with an insulated cold pack
Discreet, unbranded outer packaging
This product is a distinct combined formulation of retatrutide and cagrilintide, offered in a declared quantity of 30+5mg. It is important to note that this specific listing is separate from other 45mg retatrutide and cagrilintide products or individual component bundles. Researchers should use the exact product name when requesting any associated documentation. This material is strictly for laboratory research purposes and is not intended for human or animal consumption.
Every Evora batch is third-party tested before release. See the certificate of analysis on our COAs page.
Loading reviews…
Injection site guide
Choose the right injection area
Use the abdomen or the upper legs. Divide the area you choose into four sections and move to a new section each week, so the same spot is not used again too soon.
- Abdomen or upper legs
- Switch injection sites weekly
- At least one finger width from the last injection
- At least 5 cm away from the navel
General guidance only. Always follow the instructions supplied with your product.
Verify your productCheck the batch on your vial against our published lab reports.
Verify Your Product
UK delivery is a flat £10.00 with tracking (international £35.00). Orders placed before 2pm Monday to Friday are dispatched the same day.
International shipping is available to selected countries. See our shipping policy for details.
RETAKLIK 2.0 (RETATRUTIDE + CAGRILINTIDE) 30+5mg: product information
RETAKLIK 2.0 is a single combined formulation of retatrutide (30mg) and cagrilintide (5mg). It is a different product from our 45mg retatrutide and cagrilintide formulation and from the bundles that supply each peptide in its own vial, so always quote the exact product name when asking for batch documentation.
Frequently asked questions
What is in RETAKLIK 2.0?
Retatrutide 30mg and cagrilintide 5mg in one formulation. Retatrutide (research code LY3437943) is an investigational peptide that acts on the GIP, GLP-1 and glucagon receptors. Cagrilintide is a long-acting amylin analogue.
Is RETAKLIK a licensed medicine?
No. Neither retatrutide nor cagrilintide is a licensed medicine in the UK. RETAKLIK is supplied as a research compound only.
Is there a certificate of analysis?
Yes. Batches are sent for independent third-party testing (identity and HPLC purity). Find the batch number on your label and search it on our COAs page to see the lab report.
How should it be stored?
Keep the lyophilised (freeze-dried) powder refrigerated at 2–8°C and away from light, or frozen at −20°C for long-term storage. The expiry date is printed on the label.
How much is delivery?
UK delivery is a flat £10 with Royal Mail tracking; orders placed before 2pm on a working day are dispatched the same day. International delivery is £35.
Related products: RETATRUTIDE & CAGRILINTIDE 45mg · Reta + Cag bundle · KLIKTIDE (CAGRILINTIDE) 10mg · RETATRUTIDE 40mg · Lab reports (COAs)
